Theradiag
ALTER | PA
Overview
Corporate Details
- ISIN(s):
- FR00140069U4
- LEI:
- 969500CDG241WHIFL611
- Country:
- France
- Address:
- 14 RUE AMBROISE CROIZAT, 77183 CROISSY-BEAUBOURG
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Established on the diagnostics market for 30 years, Theradiag is now recognized as a key player in the development, manufacturing and marketing of innovative in-vitro diagnostic products, but also as a pioneer in Theranostics. This extensive experience in the field of diagnostics, combined with the reliability of our products and the performance of our customer service, enable us to address biologists as a high-quality partner with ISO 13 485 certifications. Present in more than 70 countries, through its in vitro diagnostic activities and benefiting from strong growth in Theranostics, Theradiag brings together a whole range of unique and innovative skills to provide a personalized response to each of its customers, biologists and clinicians. Theradiag is a leader in Theranostics and in the monitoring of autoimmune diseases, which is the third leading cause of morbidity in the world.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-12-20 13:02 |
Regulatory News Service
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 265.7 KB | |
| 2023-12-15 18:00 |
Share Issue/Capital Change
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 304.7 KB | |
| 2023-12-07 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 169.5 KB | |
| 2023-10-11 17:45 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 300.2 KB | |
| 2023-10-11 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 302.7 KB | |
| 2023-09-29 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 328.5 KB | |
| 2023-09-18 07:30 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 249.0 KB | |
| 2023-09-18 07:30 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 270.0 KB | |
| 2023-07-17 07:30 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 298.0 KB | |
| 2023-07-17 07:30 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 286.1 KB | |
| 2023-07-05 17:45 |
Transaction in Own Shares
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 271.7 KB | |
| 2023-07-04 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 175.2 KB | |
| 2023-06-01 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 206.2 KB | |
| 2023-05-09 17:45 |
General Meeting Notice
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 174.7 KB | |
| 2023-04-27 17:45 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 6.0 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |